Intellinetics, Inc. INLX
5.15
0.00
0.00%
as of 25 Sep
- Market cap
- $23.2M
- P/E
- 0.0×
Follow INLX
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
1.52 | 2.01 | 2.07 | 3.06 | |
P/FCF ratio |
0.00 | 0.00 | 312.31 | 64.16 | |
P/Operating CF |
580.04 | (143.29) | (64.78) | 37.50 | |
P/B ratio |
2.50 | 3.13 | 3.02 | 4.43 | |
Price to Tangible BV |
18.93 | 17.41 | 12.77 | 19.34 | |
EV/Sales |
1.42 | 1.89 | 1.92 | 2.88 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
36.06 | 41.98 | 34.17 | 29.74 | |
EV/FCF |
(328.63) | (431.91) | 290.36 | 60.25 | |
Quick Ratio |
0.62 | 0.78 | 0.93 | 0.88 | |
Current Ratio |
0.75 | 0.90 | 1.03 | 0.99 | |
Net Debt/EBITDA |
2.06 | 2.29 | (20.63) | 67.78 | |
Debt/Assets |
0.54% | 0.61% | 0.67% | 0.73% | |
Debt/Equity |
0.01 | 0.01 | 0.01 | 0.01 | |
Asset Turnover |
0.99 | 0.94 | 0.92 | 0.89 | |
Operating CF/Net income |
(0.04) | 0.19 | 2.55 | (3.65) | |
Capex/Depreciation |
(0.50) | (0.63) | (0.44) | (0.62) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
86.87% | 85.99% | 63.19% | 65.77% | |
Intangible Assets out of Total Assets |
0.54 | 0.52 | 0.50 | 0.49 | |
Share Based Compensation of Revenue |
16.66% | 6.74% | 3.59% | 4.16% | |
Graham Net Nets |
(0.08) | (0.04) | (0.02) | (0.02) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(11.64%) | (7.11%) | (5.39%) | (3.38%) | |
Free Cash Flow Yield |
(0.28%) | (0.22%) | 0.32% | 1.56% | |
Revenue per Share |
0.88 | 0.89 | 1.01 | 0.91 | |
Operating CF per Share |
0.01 | (0.05) | (0.12) | 0.31 | |
Capex per Share |
(0.03) | (0.05) | (0.03) | (0.05) | |
Free Cash Flow per Share |
(0.02) | (0.10) | (0.16) | 0.26 | |
Cash per Share |
0.38 | 0.47 | 0.59 | 0.73 | |
Shareholders Equity per Share |
2.20 | 2.38 | 2.65 | 2.61 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.20 | 2.38 | 2.65 | 2.61 | |
Free Cash Flow |
(0.11) | (0.43) | (0.68) | 1.15 | |
Working Capital |
(1.30) | (0.53) | 0.17 | (0.08) | |
Capital Expenditures |
(0.15) | (0.20) | (0.15) | (0.21) | |
Net Current Asset Value |
(2.01) | (1.28) | (0.69) | (1.05) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.04 | 0.05 | 0.03 | 0.05 | |
Net Profit Margin |
(27.52%) | (30.13%) | (4.81%) | (9.24%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
1.66 | 2.19 | 2.28 | 2.04 | |
Average Payables |
0.43 | 0.43 | 0.30 | 0.35 | |
Average Inventory |
0.14 | 0.12 | 0.14 | 0.10 | |
Average Assets |
16.40 | 17.21 | 17.94 | 18.51 | |
Average Common Equity |
10.68 | 10.41 | 11.01 | 10.94 |
Columns are period end dates